Related Experiment Video
Updated: Jul 11, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Urokinase thrombolysis in acute-on-chronic vascular occlusion of lower limb
Chandra P Shrivastava1, Sanjeev Devgarha
1Department of Cardiothoracic and Vascular Surgery, SMS Medical College & Hospital, H-16, Chitranjan Marg, C-Scheme, Jaipur-302001, Rajasthan, India. cps_sms@hotmail.com
Insights
Preoperative thrombolysis with urokinase significantly improved outcomes for patients with acute-on-chronic lower limb vascular occlusion, enhancing surgical success and long-term claudication distance.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Thrombolytic Therapy
Background:
- Acute-on-chronic lower limb vascular occlusion presents a significant challenge in vascular surgery.
- Thrombolysis is a potential treatment modality, but its impact on subsequent surgical outcomes requires further elucidation.
Purpose of the Study:
- To evaluate the efficacy of preoperative thrombolysis using urokinase in patients with acute-on-chronic lower limb vascular occlusion.
- To assess the impact of thrombolysis on the success of subsequent arterial surgical interventions and long-term patient outcomes.
Main Methods:
- A cohort of 70 patients with acute-on-chronic lower limb vascular occlusion underwent thrombolysis with urokinase.
- Patients were divided into responders (Group 1) and non-responders (Group 2) based on initial symptomatic improvement.
- All patients subsequently underwent surgical intervention (polytetrafluoroethylene graft or arterioplasty).
Main Results:
- Seventy-six percent of patients (53/70) showed symptomatic improvement with thrombolysis (Group 1).
- A significantly higher proportion of Group 1 patients achieved a good response to surgical treatment (92%) compared to Group 2 (41%).
- Improved claudication distance at 6 months was observed in 85% of Group 1 patients versus 38% of Group 2 patients.
Conclusions:
- Preoperative thrombolysis with urokinase is an effectiveadjunct in managing acute-on-chronic lower limb vascular occlusion.
- Thrombolysis improves the success rate of subsequent arterial surgery and enhances long-term functional recovery.
- Symptomatic response to thrombolysis predicts a favorable outcome following surgical intervention.
Abstract:
Between January 2000 and June 2003, 70 patients (63 men and 7 women) with acute-on-chronic lower limb vascular occlusion underwent thrombolysis with 1 million units of urokinase. Forty-eight patients had unilateral and 22 had bilateral involvement; 9 had gangrenous changes. The mean age was 47 +/- 9 years, 73% were smokers, and 13% had diabetes. The definition of a good response was either return of distal pulses or a warm limb and relief of pain at rest. Fifty-three (76%) patients (including 5 with gangrenous changes) had symptomatic improvement with thrombolysis (group 1), and 17 (24%) did not respond (group 2). All 70 patients (including 7 who later required amputation) underwent surgical intervention with a polytetrafluoroethylene interposition graft or arterioplasty. A good response to surgical treatment was found in significantly more patients (49/53, 92%) in group 1 compared to group 2 (7/17, 41%). Claudication distance after 6 months of follow-up improved in a significantly higher percentage of patients in group 1 (85%) than group 2 (38%). Preoperative thrombolysis improved the outcome and predicted the result of arterial surgery.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
